Patrice Dubreuil
Affiliations: | INSERM, Rennes, Bretagne, France |
Google:
"Patrice Dubreuil"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| François A Lemonnier | grad student | 1981- | Immunology Centre of Marseille-Luminy (CIML) (Cell Biology Tree) |
| Patrice Mannoni | post-doc | 1984- | University of Alberta, Edmonton, Canada (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Weisberg E, Meng C, Case AE, et al. (2019) Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. British Journal of Haematology |
| Martinez-Anton A, Gras D, Bourdin A, et al. (2018) KIT as a therapeutic target for non-oncological diseases. Pharmacology & Therapeutics |
| Janovec V, Aouar B, Font-Haro A, et al. (2018) The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells. Frontiers in Immunology. 9: 364 |
| Malbec O, Cassard L, Albanesi M, et al. (2016) Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Science Signaling. 9: ra126 |
| Lopez S, Voisset E, Tisserand JC, et al. (2016) An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia. Oncotarget |
| Chaix A, Arcangeli ML, Lopez S, et al. (2014) KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570 Oncogene. 33: 872-881 |
| D'allard D, Gay J, Descarpentries C, et al. (2013) Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket. Plos One. 8: e60961 |
| Georgin-Lavialle S, Lhermitte L, Suarez F, et al. (2012) Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor. European Journal of Haematology. 89: 47-52 |
| Chaix A, Lopez S, Voisset E, et al. (2011) Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells Journal of Biological Chemistry. 286: 5956-5966 |
| Voisset E, Lopez S, Dubreuil P, et al. (2007) The tyrosine kinase FES is an essential effector of KITD816V proliferation signal Blood. 110: 2593-2599 |